Inhibition of insulin, glucose-dependant insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion by octreotide has no effect on post-heparin plasma lipoprotein lipase activity

被引:11
|
作者
Ranganath, LR [1 ]
Beety, JM
Morgan, LM
机构
[1] Epsom Gen Hosp, Dept Chem Pathol, Epsom KT18 7EG, Surrey, England
[2] Univ Surrey, Sch Biol Sci, Guildford GU2 5XH, Surrey, England
关键词
obesity; insulin; GIP; GLP-1; octreotide; heparin; plasma lipoprotein lipase activity;
D O I
10.1055/s-2007-978729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study examines the immediate effect of modulating postprandial insulin and insulinotropic hormone (glucose-dependent insulinotropic polypeptide, GIP; glucagon-like peptide-1, GLP-1) secretion on the activation of lipoprotein lipase (LPL) in six lean and six obese age-matched women. Subjects were given, on two separate occasions, 340 kcal of carbohydrate alone or combined with an IV infusion of octreotide, (100 mu g infusion from 30 min before the meal for 150 min). Post-heparin LPL activity (10,000 U) was measured on each occasion 120 minutes post-carbohydrate. Following oral carbohydrate postprandial plasma insulin levels were significantly higher in obese subjects than in lean (p<0.01), Glucose tolerance was slightly impaired in obese subjects. Insulin, GIP and GLP-1 secretion post-carbohydrate was markedly reduced by octreotide in lean and obese subjects. LPL activity was similar in the two groups after carbohydrate administration and was unaffected by octreotide. Inhibition of postprandial insulin, GIP and GLP-1 secretion acutely did not reduce post-heparin LPL activity either in lean or obese subjects.
引用
收藏
页码:262 / 266
页数:5
相关论文
共 50 条
  • [41] GLUCAGON-LIKE PEPTIDE-1 (GLP-1) HAS NO EFFECT ON PERIPHERAL VASODILATATION BUT AUGMENTS CORONARY MICROCIRCULATORY FLOW IN HUMANS
    Hoole, Stephen P.
    Clarke, Sophie
    Giblett, Joel
    Aetesam-ur-Rahman, Muhammad
    Zhao, Tian
    West, Nick
    Cheriyan, Joseph
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 20 - 20
  • [42] Glucagon-like peptide-1 (GLP-1) has no effect on peripheral vasodilation but augments coronary microcirculatory flow in humans
    Clarke, S. J.
    Giblett, J. P.
    Zhao, T.
    Hubsch, A.
    Yang, L.
    Dutka, D.
    Cheriyan, J.
    Hoole, S. P.
    DIABETOLOGIA, 2017, 60 : S234 - S235
  • [43] The Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists (GLP-1RA) on Postprandial Glucagon Secretion Independent of the Gastric Emptying Rate
    Frandsen, Christian S.
    Ostergaard, Lauge
    Dejgaard, Thomas F.
    Sondergaard, Bo
    Holst, Jens J.
    Madsbad, Sten
    DIABETES, 2016, 65 : A278 - A278
  • [44] The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill
    Lee, Michael Y.
    Fraser, Jonathan D.
    Chapman, Marianne J.
    Sundararajan, Krishnaswamy
    Umapathysivam, Mahesh M.
    Summers, Matthew J.
    Zaknic, Antony V.
    Rayner, Christopher K.
    Meier, Juris J.
    Horowitz, Michael
    Deane, Adam M.
    DIABETES CARE, 2013, 36 (10) : 3333 - 3336
  • [45] Increased insulin clearance in mice with double deletion of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors
    Tura, Andrea
    Bizzotto, Roberto
    Yamada, Yuchiro
    Seino, Yutaka
    Pacini, Giovanni
    Ahren, Bo
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2018, 314 (05) : R639 - R646
  • [46] The ethanol augmentation of glucose-induced insulin secretion is abolished by calcium antagonism with nifedipine: No evidence for a role of glucagon-like peptide-1 (GLP-1)
    Svartberg, J
    Holst, JJ
    Gutniak, M
    Adner, N
    PANCREAS, 1998, 16 (01) : 66 - 71
  • [47] Gastrointestinal Incretins-Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary Artery Disease-State of the Art
    Jonik, Szymon
    Marchel, Michal
    Grabowski, Marcin
    Opolski, Grzegorz
    Mazurek, Tomasz
    BIOLOGY-BASEL, 2022, 11 (02):
  • [48] Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus
    Cypryk, Katarzyna
    Vilsboll, Tina
    Nadel, Iwona
    Smyczynska, Joanna
    Holst, Jens Juul
    Lewinski, Andrzej
    GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (01) : 58 - 62
  • [49] INSULIN-SECRETION, GLUCAGON-LIKE PEPTIDE-1 AND GASTRIC-INHIBITORY POLYPEPTIDE AFTER ORAL GLUCOSE IN CIRRHOSIS
    KRUSZYNSKA, YT
    GHATEI, M
    BLOOM, SR
    MCINTYRE, N
    HEPATOLOGY, 1993, 18 (04) : A270 - A270
  • [50] Racial differences in glucagon-like peptide-1 (GLP-1) and insulin secretion during oral glucose tolerance test in obese non-diabetic subjects
    Velasquez-Mieyer, PA
    Umpierrez, GE
    Lustig, RH
    Cashion, AK
    Cowan, PA
    Burghen, GA
    DIABETES, 2002, 51 : A362 - A362